EdwardFPatzMD

Professor of , Duke University

Dr. Patz is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Brigham and Women's Hospital/Harvard Medical SchoolResidency, Radiology-Diagnostic, 1986 - 1990
Boston VA Healthcare System (Brockton-West Roxbury)Internship, Transitional Year, 1985 - 1986
University of Maryland School of MedicineClass of 1985

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

PubMed

1 citations
Antitumor Immune Mechanisms of the Anti-Complement Factor H Antibody GT103.
Ryan T Bushey, Ruchi Saxena, Michael J Campa, Elizabeth B Gottlin, You-Wen He
Molecular Cancer Therapeutics. 2023-06-01
7 citations
Mediastinal Lymphadenopathy in the National Lung Screening Trial (NLST) Is Associated with Interval Lung Cancer.
Hamid Chalian, H P McAdams, Youkyung Lee, Fenghai Duan, Yanning Wu
Radiology. 2021-11-23
4 citations
Genetic Variants of CLEC4E and BIRC3 in Damage-Associated Molecular Patterns-Related Pathway Genes Predict Non-Small Cell Lung Cancer Survival.
Lihua Liu, Hongliang Liu, Sheng Luo, Edward F. Patz, Carolyn Glass
Frontiers in Oncology. 2021-10-06

Role Of Humoral Immunity In MetastasisNational Center For Research Resources2010
Imaging EGFR With Micro-Pet And I-124National Center For Research Resources2009
Discovery Of Biomarkers For Lung Cancer MetastasisNational Cancer Institute2005–2009
Role Of Cypa As A Molecular Imaging Or Therapeutic TargetNational Center For Research Resources2004–2006
Development Of Novel Tumor Imaging AgentsNational Cancer Institute2000–2001